Balance Labs, Inc. (BLNC)
OTCMKTS
· Delayed Price · Currency is USD
0.1830
-0.0095 (-4.94%)
At close: Apr 8, 2025
Balance Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | - | - | 0.25 | 0.62 | 1 | Upgrade
|
| Revenue Growth (YoY) | - | - | -60.37% | -37.54% | 29903.00% | Upgrade
|
| Cost of Revenue | 0.19 | 0.06 | 0.05 | 0.15 | 0.16 | Upgrade
|
| Gross Profit | -0.19 | -0.06 | 0.2 | 0.48 | 0.84 | Upgrade
|
| Selling, General & Admin | 0.09 | 0.06 | 0.22 | 0.25 | 0.23 | Upgrade
|
| Operating Expenses | 0.09 | 0.06 | 0.22 | 0.25 | 0.23 | Upgrade
|
| Operating Income | -0.27 | -0.12 | -0.02 | 0.22 | 0.61 | Upgrade
|
| Interest Expense | -0.23 | -0.22 | -0.23 | -0.24 | -0.21 | Upgrade
|
| Interest & Investment Income | - | - | 0 | 0.05 | - | Upgrade
|
| Earnings From Equity Investments | - | - | -0.05 | -0.01 | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | -0.5 | -0.34 | -0.3 | 0.02 | 0.31 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.03 | -0.04 | -0.32 | -1.02 | 0.04 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.15 | - | Upgrade
|
| Other Unusual Items | - | - | -0.15 | 0.03 | - | Upgrade
|
| Pretax Income | -0.53 | -0.38 | -0.77 | -0.81 | 0.35 | Upgrade
|
| Earnings From Continuing Operations | -0.53 | -0.38 | -0.77 | -0.81 | 0.35 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 0.01 | 0.01 | Upgrade
|
| Net Income | -0.53 | -0.38 | -0.77 | -0.8 | 0.36 | Upgrade
|
| Net Income to Common | -0.53 | -0.38 | -0.77 | -0.8 | 0.36 | Upgrade
|
| Shares Outstanding (Basic) | 22 | 22 | 22 | 22 | 22 | Upgrade
|
| Shares Outstanding (Diluted) | 22 | 22 | 22 | 22 | 25 | Upgrade
|
| Shares Change (YoY) | - | - | - | -13.02% | 14.97% | Upgrade
|
| EPS (Basic) | -0.02 | -0.02 | -0.04 | -0.04 | 0.02 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.02 | -0.04 | -0.04 | 0.02 | Upgrade
|
| Free Cash Flow | -0.16 | -0.12 | 0.01 | -0.06 | -0.22 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | - | -0.00 | -0.01 | Upgrade
|
| Gross Margin | - | - | 79.86% | 76.71% | 84.29% | Upgrade
|
| Operating Margin | - | - | -9.23% | 35.93% | 61.25% | Upgrade
|
| Profit Margin | - | - | -310.44% | -127.55% | 35.78% | Upgrade
|
| Free Cash Flow Margin | - | - | 3.13% | -9.11% | -21.80% | Upgrade
|
| EBITDA | - | - | -0.02 | 0.22 | 0.61 | Upgrade
|
| EBITDA Margin | - | - | -9.19% | 35.94% | 61.27% | Upgrade
|
| D&A For EBITDA | - | - | 0 | 0 | 0 | Upgrade
|
| EBIT | -0.27 | -0.12 | -0.02 | 0.22 | 0.61 | Upgrade
|
| EBIT Margin | - | - | -9.23% | 35.93% | 61.25% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.